Molina Healthcare is expected to report Q3 2026 revenue of $10.85 billion and EPS of $0.72, with the stock currently trading near $207.42 against an average analyst target of $209.12.
The primary focal point for investors is the Consolidated Medical Care Ratio (MCR), which analysts expect to climb to 93% for the Q3 2026 period.
Recent performance has been pressured by a projected 12.7% year-over-year decline in total membership and rising medical cost trends impacting the broader managed care sector.
Management’s commentary on the 2027 preliminary outlook and updates on Medicaid redetermination impacts will be critical for stabilizing investor sentiment regarding future margins.